Motor and Non-motor Symptoms

NeuroWiki

Clinical Manifestations of Parkinson's Disease: Motor & Non-Motor Features

Parkinson's disease is far more than a tremor disorder. It is a progressive, multi-system neurodegenerative disease with a prodromal phase spanning years to decades before the first motor symptom, and a clinical course that ultimately involves nearly every organ system. Understanding the full clinical phenotype — from the earliest prodromal signs to the advanced non-motor complications that drive disability and mortality — is essential for timely diagnosis, accurate staging, and comprehensive management. This article systematically reviews the motor and non-motor manifestations of PD, how to elicit them on examination, how they evolve over the disease course, and when they should raise concern for alternative diagnoses.

🔹 Bottom Line: PD Clinical Manifestations

The prodromal phase — hyposmia, RBD, constipation, depression — may precede motor onset by 10–20 years. By the time the first motor symptom appears, ~50–60% of nigral dopaminergic neurons have already been lost.
Bradykinesia is the mandatory motor feature: defined as slowness with progressive reduction in speed AND amplitude (decrement) — not just slowness from weakness, pain, or aging.
Rest tremor is the most common presenting complaint (~70%), but ~30% of PD patients are atremulous. Tremor-dominant PD carries a better prognosis than the PIGD subtype.
Gait abnormalities evolve predictably: reduced arm swing → shuffling → festination → freezing of gait. Freezing is a major cause of falls and disability.
Postural instability within the first 3 years is a red flag for PSP or MSA — in PD, it typically emerges at Hoehn & Yahr stage 3 or later.
Non-motor symptoms affect virtually every organ system and are often more disabling than motor features — including cognitive decline (cumulative PDD ~80%), psychosis (20–40%), OH (30–50%), and chronic pain (40–70%).

The Earliest Symptoms: From Prodrome to Diagnosis

PD has one of the longest prodromal phases of any neurodegenerative disease. Decades before the first motor symptom, patients may experience a constellation of non-motor features representing the earliest signs of α-synuclein-mediated neurodegeneration spreading through the peripheral and central nervous system — consistent with the Braak staging hypothesis of ascending pathology from the enteric nervous system and olfactory bulb toward the brainstem and cortex.

Prodromal non-motor features and their approximate lead times before motor diagnosis:

Constipation — may precede motor onset by >15–20 years; reflects enteric nervous system α-synuclein pathology
Hyposmia/anosmia — 80–90% of PD patients; precedes motor onset by ~5–10 years; reflects olfactory bulb involvement
REM sleep behavior disorder (RBD) — precedes motor PD by 5–15 years; the strongest individual prodromal predictor (likelihood ratio >100)
Depression and anxiety — may precede motor onset by >5 years; often attributed to life circumstances rather than recognized as prodromal
Excessive daytime sleepiness — may precede motor symptoms by several years

The first motor symptom is most commonly a unilateral rest tremor in one hand (~70% of patients). Others present with subtle unilateral bradykinesia — difficulty with fine motor tasks, a "clumsy" or "stiff" hand, or a feeling that one side is "not working properly." What patients and families typically notice first:

Reduced arm swing on one side during walking (often noticed by a spouse before the patient)
Micrographia — progressively smaller handwriting, often within a single sentence
Dragging one leg, or a foot that "scuffs" the ground
Quiet voice (family asks "why are you whispering?")
Shoulder stiffness (often misdiagnosed as frozen shoulder or rotator cuff pathology)
General slowing — "he just seems to have lost his spark"

The typical diagnostic delay from first motor symptom to PD diagnosis is approximately 1–2 years, and even longer from first prodromal symptom.

Cardinal Motor Features

Rest Tremor

The classic PD rest tremor is a 4–6 Hz, rhythmic oscillation most prominent when the limb is fully at rest and supported against gravity. The archetypal "pill-rolling" tremor involves alternating flexion-extension of the fingers and thumb.

Key characteristics:

Attenuates or disappears with voluntary action
Increases with mental concentration, emotional stress, or contralateral limb movement
Distribution follows a characteristic progression: unilateral hand → ipsilateral leg → contralateral hand → contralateral leg → chin/jaw
Head tremor (titubation) is rare in PD — suspect essential tremor or dystonic tremor
Lip and chin tremor ("rabbit tremor") is relatively specific to PD

Re-emergent postural tremor: When the patient extends their arms, there is initially no tremor. After a latency of 5–15 seconds, the rest tremor "re-emerges." This is distinct from the immediate-onset postural tremor of ET and reflects the re-establishment of the central oscillatory PD tremor circuit.

Examination tips to elicit or augment subtle rest tremor:

Have the patient perform a distracting cognitive task — serial 7 subtractions, months of the year backward, or opening/closing the contralateral hand
Observe the patient's hands at rest during history-taking — tremor is often most visible when the patient is not self-conscious
Watch for tremor in the legs while sitting (foot tremor) — an often-overlooked finding

Rigidity

Rigidity in PD is increased resistance to passive movement that is present throughout the range of motion, in both flexion and extension, and is independent of the velocity of passive movement — the key feature distinguishing it from spasticity.

Two patterns:

Lead-pipe rigidity — smooth, constant resistance throughout the range
Cogwheel rigidity — ratchety, intermittent quality superimposed on lead-pipe resistance, resulting from the interaction of rigidity with the underlying tremor oscillation. Cogwheel can be present even when tremor is not visible (subclinical tremor)

How to test:

Passively flex/extend the wrist, then the elbow, slowly and steadily
Test the neck by gently rotating the head
To augment subtle rigidity, use the Froment maneuver: ask the patient to open and close the contralateral hand while you re-test the limb. Genuine PD rigidity increases with contralateral activation

🔹 Clinical Relevance: Rigidity vs Gegenhalten (Paratonia)

Gegenhalten (paratonia) is involuntary resistance that increases in proportion to the speed and force of the examiner's movement — the patient appears to "resist" your examination. It is NOT true parkinsonian rigidity.
Seen in frontal lobe pathology (FTD, advanced dementia, NPH). Can be mistaken for PD rigidity, leading to misdiagnosis.
Key distinction: PD rigidity is constant regardless of speed and augments with Froment. Gegenhalten varies with examiner speed/force, worsens when the patient tries to "relax," and does not augment with Froment.
Mitgehen — the opposite phenomenon where the limb "follows" the examiner's movement (facilitory paratonia) — also reflects frontal dysfunction.
Tip: If you suspect gegenhalten, slow your passive movements, distract the patient with conversation, and re-examine — gegenhalten often diminishes; PD rigidity persists.

Feature	PD Rigidity	Spasticity	Gegenhalten (Paratonia)
Velocity dependence	Independent — same at any speed	Velocity-dependent — increases with faster movement	Force/speed-dependent — increases with greater examiner force
Range	Constant throughout range (lead-pipe)	Maximal at start, then gives way (clasp-knife)	Variable; often entire range
Distribution	Flexors and extensors equally; often asymmetric	Flexors > extensors (UL); extensors > flexors (LL)	All directions; often bilateral
Froment maneuver	Augments rigidity	No significant change	No augmentation; may decrease with distraction
Associated signs	Cogwheel, bradykinesia, rest tremor	Hyperreflexia, Babinski, clonus	Frontal release signs (grasp, palmomental)
Pathology	Basal ganglia (nigrostriatal dopamine loss)	Upper motor neuron (corticospinal tract)	Frontal lobe / diffuse cortical

Bradykinesia

Bradykinesia is the mandatory motor feature for the diagnosis of parkinsonism. It is defined as slowness of movement with progressive reduction in speed and amplitude (decrement) on repetitive actions. The decrement — the hallmark of parkinsonian bradykinesia — distinguishes it from simple slowness due to weakness, pain, aging, or upper motor neuron dysfunction.

Examination tasks (MDS-UPDRS Part III):

Finger tapping — tap index finger and thumb as quickly and as largely as possible (10 reps)
Hand movements — open and close the hand rapidly
Pronation-supination — alternate palm-up/palm-down as rapidly and fully as possible
Toe tapping and leg agility (foot stomping)
For each task, observe three components: (1) speed, (2) amplitude, and (3) progressive decrement (the most specific finding). Also note hesitations, halts, and freezing during repetitive movements

🔹 Bradykinesia: Clinical Manifestations by Body Region

Face — Hypomimia (masked facies): Reduced facial expression, decreased blink rate (normal 15–20/min; PD often <10/min), staring appearance, loss of spontaneous smiling. Often mistaken for depression.
Voice — Hypophonia: Reduced volume, monotone speech (loss of prosody), breathy quality. Festinating speech: involuntary acceleration with reduced volume — the vocal equivalent of festinating gait.
Handwriting — Micrographia: Progressive reduction in letter size, often within a single sentence. One of the earliest self-reported symptoms.
Upper limb — Loss of dexterity: Difficulty with buttons, zippers, utensils, typing. Reduced arm swing on one side — often the first sign noticed by others.
Trunk — Axial bradykinesia: Difficulty turning in bed (multiple segmented movements instead of one fluid motion), difficulty rising from a chair (multiple attempts, arm push-off).
Lower limb — Gait bradykinesia: Reduced stride length, reduced step height, start hesitation. Gait deteriorates with dual-tasking (talking + walking).
Global — Loss of automatic movements: Reduced spontaneous gesturing, decreased fidgeting, overall impression of stillness. The "reptilian stare" — hypomimia + reduced blink rate + absent spontaneous movement.

Postural Instability

Postural instability — the loss of postural reflexes leading to impaired balance and falls — is typically a late motor feature of PD (Hoehn & Yahr stage 3+). Its presence within the first 3 years is a red flag for PSP or MSA.

The pull test (retropulsion test):

Stand behind the patient; warn them ("I'm going to pull you backward; try to keep your balance")
Deliver a brisk, firm pull on the shoulders
Normal: one corrective step. Abnormal: >2 corrective steps (retropulsion) or falling into examiner's arms
Always give a practice trial — false positives occur when the patient is unprepared or anxious

Feature	PD	PSP	MSA	DLB
Onset of instability	Late (H&Y ≥3, typically >5 yr)	Early (first 1–3 yr; often presenting feature)	Early-moderate (2–5 yr)	Variable; linked to cognitive fluctuations
Fall direction	Primarily backward (retropulsion)	Backward; reckless, "toppling like a tree"	Multidirectional (cerebellar + parkinsonian)	Variable; often related to OH or inattention
Protective reflexes	Preserved early; lost late	Lost early ("reckless" falling without arm extension)	Impaired by cerebellar and autonomic dysfunction	Impaired during cognitive "off" periods
Key contributors	PIGD subtype, cognitive decline, FOG, OH	Axial rigidity, frontal dysfunction, gaze palsy	Cerebellar ataxia + parkinsonism + OH	Fluctuating attention, OH, hallucinations

Falls in PD are multifactorial:

Motor: FOG, postural instability, festination, dyskinesia
Non-motor: orthostatic hypotension, cognitive impairment (impaired attention/executive function), medication effects (sedation, orthostasis), visual impairment
PIGD motor subtype carries the highest fall risk
Falls are a leading cause of morbidity (hip fractures, subdural hematomas) and mortality in advanced PD

Gait Abnormalities

Gait impairment is one of the most disabling and progressive features of PD. The parkinsonian gait evolves through a characteristic sequence as disease advances:

Gait Type	Description	Clinical Significance
Reduced arm swing	Unilateral loss of natural arm swing during walking — often the earliest visible motor sign, noticed by a companion	May precede other motor symptoms by months. Asymmetric arm swing is a soft sign for early PD
Shuffling gait	Reduced step height; feet barely clearing the floor; sliding, scraping quality; loss of heel-strike pattern	Increases trip-and-fall risk. Distinguish from the wide-based shuffling of NPH or frontal gait disorder
Short-stepped (petit pas)	Markedly reduced stride length with preserved or increased cadence; small, rapid steps	Creates the appearance of "hurrying with tiny steps." Not synonymous with festination (which implies acceleration)
Festinating gait	Involuntary progressive acceleration of stepping with forward trunk flexion — patient appears to be chasing their displaced center of gravity	High risk for forward falls. Triggered by slopes, doorways, postural perturbation. Often coexists with freezing
Freezing of gait (FOG)	Sudden, transient inability to initiate or continue stepping despite intention to walk; feet appear "glued to the floor"; episodes last seconds; upper body may continue forward (→ falls)	Triggered by doorways, narrow spaces, turns, crowds, dual-tasking, anxiety. Major cause of falls. Often levodopa-resistant in advanced disease
Start hesitation	Difficulty initiating the first step after standing still — a specific form of freezing at gait initiation	May respond to cueing strategies. Distinct from the "magnetic gait" of NPH (stuck throughout gait cycle)
En bloc turning	Loss of segmental body rotation during turns — head, trunk, and legs turn as a single rigid unit requiring multiple small steps	Normal turning: eyes → head → shoulders → hips → feet (sequential). PD: lost. Increases turn time and fall risk

Postural Deformities

Camptocormia: Marked involuntary forward trunk flexion (>45°) during standing/walking that resolves when supine. Pathophysiology debated — axial dystonia, paraspinal myopathy, or both. Seen in PD and MSA. A lesser degree of stooped posture ("simian posture") is nearly universal in moderate PD.
Pisa syndrome (pleurothotonus): Sustained lateral trunk flexion (>10°). May relate to dopaminergic medication changes. More commonly reported with antipsychotics (tardive Pisa), but also occurs in PD.
Striatal hand: Flexion at MCP joints with extension at PIP joints (resembling ulnar deviation). More common in young-onset PD.
Striatal toe: Extension (dorsiflexion) of the great toe ± flexion of other toes — mimics a Babinski sign but represents dystonia, not pyramidal dysfunction.

🔹 Clinical Relevance: Cueing Strategies for Freezing of Gait

Visual cues: Parallel lines on the floor (tape), laser pointer on cane/walker projecting a line — patient steps over the line to break the freeze
Auditory cues: Rhythmic metronome, music with a strong beat, counting aloud ("1-2, 1-2"), companion marching cadence — external rhythm entrains the central pattern generator
Cognitive strategies: Consciously thinking about each step ("lift, step, land"), shifting weight deliberately before stepping, marching in place before forward walking
Attentional strategies: Avoid dual-tasking while walking — stop talking, stop carrying objects, focus entirely on gait
Environmental modifications: Remove doorway thresholds, avoid narrow spaces, use contrast strips at known trigger points, ensure adequate lighting

Other Motor Signs on Examination

Glabellar reflex (Myerson sign): Repeated glabellar tapping normally produces blink responses that habituate after 3–5 taps. In PD, the blink reflex fails to habituate. Sensitive but not specific — also seen in PSP, MSA, dementia, and elderly normals. Ensure tapping comes from above the visual field (avoid visual threat response).
Applause sign: Ask the patient to clap exactly three times. Inability to stop at three (continuing to clap 4, 5+ times) is positive. More suggestive of PSP than PD — reflects frontal disinhibition and motor programming impairment.
Reduced blink rate: Normal ~15–20/min; PD often <10/min. Contributes to the "staring" appearance of hypomimia and causes dry eyes/corneal irritation.
Saccadic eye movements: Smooth pursuit commonly broken into saccadic ("cogwheel") pursuit (non-specific). Hypometric saccades (undershooting target) are more characteristic. Vertical supranuclear gaze palsy — particularly slowed downward saccades → frank downgaze limitation — is a red flag for PSP and an absolute exclusion criterion for PD.
Convergence insufficiency: Difficulty converging eyes for near tasks; contributes to diplopia and reading difficulty. May be an early, underrecognized feature.
Off-period dystonia: Early-morning foot dystonia (painful inversion/plantar flexion before first levodopa dose) — common and often misdiagnosed as orthopedic pathology.
Dysphagia: Often subclinical early; affects up to 80% in late stages. Involves oral (poor bolus formation), oral propulsive (delayed transit), and pharyngeal phases (reduced contraction, delayed swallow initiation). Aspiration pneumonia is the leading cause of death in advanced PD. Screen regularly with water swallow test; refer for FEES/VFSS when clinical dysphagia is suspected.

Non-Motor Manifestations: A Systems-Based Review

Non-motor symptoms are present in virtually 100% of PD patients over the disease course and frequently are the primary determinants of quality of life, disability, caregiver burden, and institutionalization. The following is organized by organ system, from rostral to caudal.

Cognitive

PD-MCI: 20–30% prevalence at any given time. Characteristic profile is subcortical-frontal — executive dysfunction (planning, set-shifting, working memory), visuospatial deficits (clock drawing, intersecting pentagons), attentional impairment. Memory relatively preserved vs AD; when affected, it is retrieval-based (improved with cueing) rather than encoding-based
PD dementia (PDD): ~30% point prevalence, ~80% cumulative over 20 years. Risk factors: older age, longer disease duration, PIGD subtype, lower education, visual hallucinations, GBA1 mutations. Rivastigmine is the only FDA-approved treatment (EXPRESS trial)

Sleep

RBD: Dream enactment from loss of REM atonia; 30–60% of PD patients; strongest prodromal predictor (LR >100); may cause injury to patient or bed partner
Insomnia: Up to 60%; multifactorial — motor symptoms, nocturia, RBD, depression, medication effects
Excessive daytime sleepiness (EDS): 30–50%; from degeneration of wake-promoting nuclei, disrupted nocturnal sleep, or DA medications (sleep attacks)
Restless legs syndrome (RLS) and periodic limb movements (PLMS): More prevalent in PD than general population

Psychiatric

Depression: 35–50%; often the single most important QoL determinant — more disabling than motor symptoms. May precede motor onset by >5 years. Distinct neurobiological substrate involving serotonergic, noradrenergic, and dopaminergic degeneration
Anxiety: 25–40%; generalized, panic, social. In patients with motor fluctuations, anxiety often tracks with the OFF state ("non-motor fluctuations")
Apathy: 15–40%; reduced motivation independent of depression. May worsen after DBS or DA withdrawal. Significant caregiver frustration
Psychosis — evolves along a predictable spectrum:
- Passage hallucinations (fleeting peripheral shadows) → Presence hallucinations (sense of someone nearby) → Formed visual hallucinations (well-formed people/animals, often non-threatening, insight retained early) → Hallucinations with lost insight → Paranoid delusions (infidelity, theft, persecution)
- Prevalence increases with disease duration, cognitive decline, and dopaminergic load. Visual hallucinations + cognitive decline strongly predicts PDD progression
Impulse control disorders (ICDs): 15–25% on dopamine agonists (DOMINION study) — pathological gambling, hypersexuality, compulsive shopping, binge eating
Dopamine dysregulation syndrome (DDS): Compulsive, self-escalating levodopa use beyond motor need, driven by the rewarding "high" of the ON state

Eyes & Vision

Convergence insufficiency: Diplopia and difficulty reading
Reduced contrast sensitivity: Related to retinal dopamine deficiency; impairs function in low-contrast/low-light environments (contributes to falls)
Dry eyes: From reduced blink rate
Blepharospasm: Involuntary eyelid closure; may occur in advanced PD or as off-period dystonia
Color vision abnormalities: Particularly blue-green axis; reflects retinal dopaminergic dysfunction

Olfactory & Gustatory

Hyposmia/anosmia: 80–90% of PD patients; one of the earliest prodromal markers (−5–10 yr). Results from α-synuclein in olfactory bulb/anterior olfactory nucleus (Braak stage 1). Olfactory testing (UPSIT, Sniffin' Sticks) is a supportive criterion in MDS diagnostic criteria
Taste dysfunction: ~20–30%; likely reflects both olfactory loss (flavor perception requires olfaction) and gustatory nerve involvement

Cardiovascular

Neurogenic orthostatic hypotension (nOH): 30–50%; sustained drop ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 min of standing. From cardiac and vasomotor sympathetic denervation. Symptoms: lightheadedness, visual dimming, coat-hanger headache (trapezius ischemia), presyncope, syncope. All dopaminergic meds can worsen OH
Supine hypertension: Often coexists with nOH (loss of baroreceptor-mediated regulation); complicates pharmacologic management
Cardiac sympathetic denervation: Demonstrable on MIBG scintigraphy (reduced myocardial uptake); supportive MDS diagnostic criterion. Distinguishes PD/DLB from MSA and PSP (which have preserved cardiac innervation)
Reduced heart rate variability: Early autonomic feature

Respiratory

Restrictive physiology: From chest wall rigidity and axial bradykinesia — reduced vital capacity and respiratory excursion
Upper airway dysfunction: Vocal cord hypomobility and laryngeal bradykinesia — contributes to hypophonia and respiratory compromise
Obstructive sleep apnea: Common; upper airway hypotonia during sleep
Aspiration: From oropharyngeal dysphagia — the most dangerous respiratory consequence and leading cause of death in advanced PD
Inspiratory stridor — harsh, high-pitched inspiratory sound from vocal cord dysfunction — is a red flag for MSA, not PD

Gastrointestinal

Sialorrhea (drooling): From impaired automatic swallowing rather than overproduction — a manifestation of oropharyngeal bradykinesia
Dysphagia: All phases impaired — oral preparatory (poor bolus formation), oral propulsive (delayed transit), pharyngeal (reduced contraction, delayed initiation). Aspiration pneumonia = #1 cause of death
Gastroparesis: Delayed gastric emptying → bloating, early satiety, and — critically — erratic levodopa absorption (major contributor to unpredictable motor fluctuations)
Constipation: 50–80%; may precede motor symptoms by >15 years. Reflects enteric nervous system α-synuclein pathology. The most common autonomic symptom
Weight loss: Multifactorial in advanced PD — increased energy expenditure (tremor/rigidity), dysphagia, gastroparesis, depression, reduced caloric intake

Urogenital & Sexual

Overactive bladder: 40–70%; urgency, frequency, nocturia. From loss of dopaminergic inhibition of micturition reflex
Nocturia: Particularly bothersome; increases fall risk
Erectile dysfunction: ~60–70% of men; may precede motor onset
Decreased libido: Both sexes
Hypersexuality: ICD associated with dopamine agonists
Early severe urinary retention or incontinence (within first 5 years) is a red flag for MSA

Dermatologic

Seborrheic dermatitis: Greasy, flaky skin affecting nasolabial folds, eyebrows, scalp; more prevalent in PD; likely related to autonomic dysfunction of sebaceous glands
Hyperhidrosis: Generalized or focal excessive sweating; may fluctuate with motor state (profuse during OFF periods)
Melanoma: Epidemiologic studies consistently show increased melanoma risk in PD (and vice versa) — possibly related to shared melanin/neuromelanin synthesis pathways

Pain & Sensory

Pain (40–70%) — five categories:
- Musculoskeletal — most common (shoulder, back, joint stiffness)
- Dystonic — early morning foot dystonia, off-period dystonia; often severe
- Central/neuropathic — poorly localized burning or aching; central pain processing abnormality
- Radicular/neuropathic — nerve root or peripheral nerve involvement
- Akathitic — restless, uncomfortable inner urge to move; overlaps with RLS
Pain may fluctuate with motor state — worsening during OFF, improving during ON
Fatigue: ~50% of patients; one of the most bothersome NMS. Distinct from sleepiness, depression, and motor disability. No treatment has "clinically useful" MDS designation
Temperature dysregulation: Intolerance to heat or cold, inappropriate sweating; reflects autonomic dysfunction

Natural History & Progression

Phase	Timeframe	Motor Features	Non-Motor Features
Prodromal	−20 to −1 years before motor diagnosis	None or subtle: reduced arm swing, mild rigidity	Constipation, hyposmia, RBD, depression, anxiety, EDS, reduced contrast sensitivity
Early PD (H&Y 1–2)	Years 0–5	Unilateral tremor/bradykinesia → bilateral; preserved balance; excellent levodopa response; minimal dyskinesia	Sleep disturbance, fatigue, mild cognitive changes, pain, worsening constipation, urinary frequency
Moderate PD (H&Y 2.5–3)	Years 5–10	Wearing off, peak-dose dyskinesia, postural instability emerges, FOG begins, en bloc turning, falls begin	PD-MCI develops, symptomatic OH, dysphagia subclinical → clinical, psychosis spectrum begins, ICDs on DAs, pain increases
Advanced PD (H&Y 4–5)	Years 10+	Severe fluctuations, refractory FOG, frequent falls, camptocormia, wheelchair/bed-dependent, severe dysphagia	PDD (~80% cumulative), frank psychosis, severe OH, aspiration risk, weight loss, severe autonomic failure, total dependence

References

Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591–1601.
Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376.
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896–912.
Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548–560.
Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197–211.
Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011;10(8):734–744.
Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–245.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Mov Disord. 2008;23(15):2129–2170.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427–442.
Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson's disease — an evidence-based medicine review. Mov Disord. 2019;34(2):180–198.